K

Kinnevik AB Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Kinnevik AB with $65.6M in long positions as of Q3 2025, 100% allocated to Healthcare, and 100% concentrated in top 10 positions.

Portfolio Value
$65.6M
Top 10 Concentration
100%
Top Sector
Healthcare (100%)
US Exposure
100%
Market Cap Focus
Mid Cap
Countries
1

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 100.00%Healthcare
Healthcare
100.00%

Industry Breakdown

1 industry across all sectors

Biotechnology: 100.00%Biotechnology
Biotechnology
Healthcare
100.00%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 100.00%Mid Cap ($2B - $10B)
Mid Cap ($2B - $10B)
100.00%

Portfolio Concentration

Top 10 Holdings %
100.0%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
100.0%
International
-
Countries
1
United States of America
100.00% ($65.6M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
11 quarters
Avg. Top 20
11 quarters
Avg. All Positions
11 quarters
Median Holding Period
11 quarters
Persistence Rate
100.0%
Persistent Holdings Weight
100.0%
Persistent Positions
1
Longest Held
Recursion Pharmaceuticals, Inc. Class A Common Stock logo
Recursion Pharmaceuticals, Inc. Class A Common StockRXRX - 11 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.000%
Avg. Position Weight
100.00%
Largest Position
Recursion Pharmaceuticals, Inc. Class A Common Stock logo
Recursion Pharmaceuticals, Inc. Class A Common StockRXRX - 100.00%
Largest Ownership Stake
Recursion Pharmaceuticals, Inc. Class A Common Stock logo
Recursion Pharmaceuticals, Inc. Class A Common StockRXRX - 3.08%
Avg. Ownership Stake
3.08%
Ownership Stake >5%
0
Ownership Stake >1%
1

Historical (Since Q4 2021)

Avg. New Position
50.29%
Avg. Ownership Stake
3.30%
Largest Position
Recursion Pharmaceuticals, Inc. Class A Common Stock logo
Recursion Pharmaceuticals, Inc. Class A Common StockRXRX - 100.00% (Q3 2024)
Largest Ownership Stake
Recursion Pharmaceuticals, Inc. Class A Common Stock logo
Recursion Pharmaceuticals, Inc. Class A Common StockRXRX - 5.41% (Q2 2023)

Portfolio Turnover

Current Quarter

Turnover Ratio
0.0%
Value Traded
$0.00
Positions Added
0
Positions Exited
0

Historical (Since Q4 2021)

Avg. Turnover Ratio
12.0%
Avg. Positions Added
0
Avg. Positions Exited
0
Highest Turnover
58.4%
Q1 2023

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.